TABLE 1.
Study Characteristics
Trial Duration (wk) | Treatment Format | Treatment Type | Baseline Depression Scale | Definition of Remission | |
---|---|---|---|---|---|
Alexopoulos et al.4 | 8 | Standardized | Citalopram | HAM-D | 50% change in HDRS from baseline |
Alexopoulos et al.27 | 8 | Standardized | Escitalopram | HAM-D | HDRS 10 or lower |
Devanand et al.12 | 12 | Standardized | Sertraline | HAM-D | 50% change in HDRS from baseline |
Kalayam & Alexopoulos65 | 6 | Standardized | Citalopram | HAM-D | HDRS 10 or lower |
Morimoto et al.13 | 12 | Standardized | Escitalopram | HAM-D | HDRS 7 or lower |
Potter et al.66 | 12 | Algorithm | SSRI, venlafaxine, bupropion, TCA, lithium | MADRS | MADRS 7 or lower |
Sheline et al.67 | 12 | Standardized | Sertraline | MADRS | MADRS 7 or lower |
Sneed et al.56 | 8 | Standardized | Citalopram | HAM-D | 50% change in HDRS from baseline |
Note: HDRS: Hamilton Depression Rating Scale; SSRI: selective serotonin reuptake inhibitor; TCA: tricyclic antidepressant; MADRS: Montgomery-Asberg Depression Rating Scale.